Reaction: Ceftobiprole medocaril to 1 product

Reaction
Ceftobiprole medocaril
DB14733
    Ceftobiprole
    DB04918
    Reaction type
    cleavage
    Direction
    Major circulating metabolite?
    Yes
    Spontaneous?
    Yes
    Activity
    active
    References
    1. FDA Approved Drug Products: Zevtera (ceftobiprole medocaril sodium) injection for intravenous use [Link]
    2. Health Canada Product Monograph: Zevtera (ceftobiprole medocaril sodium) for intravenous injection [Link]
    Comments
    Not Available
    Enzymes
    Not Available